Robert Gallo is an unprincipled, immoral gangster and is the scientific front man for the Rockefeller eugenics agenda. His attempt to claim Luc Montagnier’s LAV as his own discovery under the name HTLV-lll is well known. His experiments upon children aged as young as two years [and to whom he referred as ‘informed volunteers’] are on the record and are developed in great detail in our work-in-progress The Crime Beyond Belief. In our article on Hilary Koprowski we have already noted Gallo’s ‘father/ son’ relationship with the former. Less well known, is Gallo’s ‘friendship’ with Dr. Carleton Gajdusek.
When Gajdusek was arrested for sexually molesting one of his adopted ‘sons’, it was Gallo who put up the bail money. We shall say more about Gajdusek later in the article, but at this point we want to make it clear that Gallo has critical links with all the main players in this tragic story of AIDS.
When the eugenics evil came to dominate the minds and social goals of the Rockefellers and they in turn used their inherited wealth [much of it criminally acquired by the family patriarch John D. Rockefeller, Sr.] to buy the media and the politicians, they needed someone in science, who had one foot in the public sector camp of government health agencies, and another foot in the camp of the private capital pharmaceutical industry who would convert the science of the Koprowski Krowd into the vaccines of the WHO smallpox campaign.
In Robert Gallo they had their man. Let’s outline the rogue’s progress as he helps convert the lunacy of eugenics into the crime beyond belief… AIDS and its mirror image…CFS.
In Gallo’s self-serving account of his career, Virus Hunting, some of what he writes is apparently true. Let’s start with one of those truths quoted from page 20:
“In Providence College I majored in biology, helped in a research project on cholesterol biosynthesis… and became interested in the thymus gland… As a strange coincidence, the focus of my research team twenty years later would be on the thymus-derived T -cells.”
Wow! A strange co-incidence, indeed.
To the average reader of this Special Edition on AIDS, this quote of 42 words appears to be making note of one or two simple facts of Gallo’s career. However, when one has spent the last nine years as we have trying to plumb the murky depths of AIDS and CFS, these 42 words are like a sample of the rot in the channel’s bottom mud. Let us explain.
When Robert Huebner found the mycoplasma in the spontaneously degenerating adenoids of some Naval recruits, [see article on Huebner above] he realized that the mycoplasma was apparently capable of doing great damage to living tissue. But he didn’t know how it all worked.
The science of how certain species of mycoplasma acted was explored by other scientists, and in the work of three of the latter, we find our first intriguing detail linking AIDS to Robert Gallo in Providence College. The three scientists, S. Rottem, E. A. Pfendt, and L. Hayflick, released the results of their research in 1970 in an article titled “Sterol Requirements of T-Strain Mycoplasmas”. The researchers demonstrated that the T-strain mycoplasmas had an absolute growth requirement for the up-take of pre-formed sterols from host cells. Such sterols included cholesterol.
Cholesterol! Take another look at what Gallo was doing when he w as a student at Providence College: “…a research project on the biosynthesis of cholesterol.” He was off to an early start. The question is: was it just a co-incidence (as he labels it) that one of the critical factors in mycoplasmal-instigated diseases happened to be the subject of early Gallo study? Or, was Gallo being prepared very early on to work in a field, which required knowledge of cholesterol biosynthesis?
Your guess is as good as ours, but we believe that there is a very strong possibility that Gallo had been identified early on for work in the ‘relevance of this field of [molecular biology] to biological warfare’ as Dr. MacArthur was later to suggest to the Congressmen (June 9, 1969) and that in ‘the mid-1950s’ Gallo was being prepared while still a college student for a future role in that warfare. We do not have the space to develop this theme here, but in our forthcoming book we look at the recruitment of college students for future service in lieu of being drafted for military service, and use the story of people like Philip Agee, Carleton Gajdusek and Edward Shorter to demonstrate our thesis.
Gallo himself acknowledges the appeal of becoming a clinical or research associate since the ‘war in Vietnam made an appointment even more desirable …as service in [NIH] was accepted in lieu of a military obligation.’
Not only had Gallo been given an early start on the role of cholesterol in the degenerative diseases, but he also had the good fortune to develop an early interest in the thymus gland. The latter glandular structure of largely lymphoid tissue with its critical role in the maintenance of the immune system was the key to a growing understanding of how that immune system could be compromised and so open the victim up to assault by opportunistic and normally innocuous diseases. It was to become a part of the Special Virus Leukemia/ Lymphoma Program [SVLP] which possibly grew out of MK-SVLP and which finally emerged as SVCP. A co-incidence? Oh what tangled webs…
Following Providence College, in 1965 Robert Gallo joined the National Institutes of Health. Things were beginning to boom at NIH. The effects of the Lyndon Johnson drive towards population control, with his appointment of John David Rockefeller lll as a co-chair of a special committee was accompanied by dramatic increases in funding for activity in that field. It was in 1965 that the SVLP got its official funding with $8.7 million and this shot up to $13.5 million by the next year. Something dramatic was going on and in Virus Hunting Gallo does his best to obfuscate just what that something was! In fact, trying to follow the action as Gallo recounts it is something like trying to track footprints through a bog.
In 1964 NIH launched what they officially called a ‘Viral Oncology Program’ [VCO] but NIH labeled it simply ‘VO’ in their public references and funded it with $4.9 million. This program was apparently initiated so that there was an executive agency which would lay the foundation for bringing all the pieces of the Koprowski, Huebner, Deinhardt, Sigurdsson, Henles’ research together and translate it into a program to produce a smallpox vaccine as a carrier for Huebner’s mycoplasma and Sigurdsson’s visna virus. The visna having been passaged through cows to emerge as bovine leukemia virus [BLV].
The VOP lasted for four years, but in its second year an offshoot called The Special Virus Leukemia/ Lymphoma Program [SVLP](note BLV above) was created with a budget of $8.7 million. The ‘leukemia/ lymphoma’ emphasis of course, ties together much of what the listed researchers were ‘publicly’ working on. SVLP lasted for three years, but in 1968 was converted to the Special Virus Cancer Program [SVCP]. At this point we can repeat a quotation from Lyndon Johnson:
“When I entered office we were investing $6 million annually for population control. During my last year in the White House (1968) that investment had grown to $115 million.”
In that last year that Johnson refers to, the official spending on the Special Virus Programs totaled $18.7 million. Where did the other $100 million (approximately) go? In response to this question, one needs to read further in Johnson’s autobiography. In the same chapter  he tells how he was able to funnel funds through the Agency for International Development [AID] which had been working with the CDC on African ‘health’ projects. Here it must be noted that Bill Foege of the AID-CDC African health projects became a key administrator when Donald Henderson launched the revived 1966 WHO smallpox program.
Convoluted? Yes, indeed, but one doesn’t set out to kill off 8,000 people a day in broad daylight (as is happening today) without doing everything possible to cover one’s tracks. So, bear with the VOP to VO to SVLP to VCP to SVCP labyrinth. It was meant to confuse you, but don’t let it! Follow the money.
End of an Interlude
So, back to Gallo.
In 1965 Gallo joined the NIH, and lo and behold… who else was a member of that burgeoning ‘health’ agency? None other than Robert Huebner who had got a lot of the action under way in the late 1940’s when he tied the degeneration of adenoids to the mycoplasma. Huebner had first joined the Infectious Disease Institute of NIH but transferred to Gallo’s Cancer Institute in 1971.
Not only was the NCI of the NIH growing in terms of personnel, but there was a physical plant growth as well, which coincided with Gallo’s arrival. It was decided in 1964 to build another office/laboratory complex to be called ‘Building 41’ (all NIH buildings were numbered for their place in the sequence of additions to the campus). Here again, there is a small detail to be noted: corresponding as it does with the launch of the SVLP, it is significant that Building 41 was referred to by NIH staffers as “The Germ Warfare Facility”.
Despite the fact that Bldg. 41 was commonly referred to as the ‘germ warfare facility’ and is even referred to that way in Robert A. Weinberg’s book Racing to the Beginning of the Road. there is no hint in Virus Hunting that Gallo had any clue that the building was even there nor had he any clue as to what was going on.
The NCI/NIH interest in Huebner’s mycoplasma is also evident in the outside research that they financed. For example, in 1965 NIH awarded a contract to Michael Gabridge and William Murphy of the University of Michigan [Contract SVLP: PH43-65-639] The subject of the Gabridge/ Murphy research was “Toxic Membrane Fractions from Mycoplasma fermentans”! For more detail on why this research is critical to any study of AIDS, see Exhibit Two in this Special Edition of JODD. In a Patent that Lo filed for the U.S. Government this mycoplasma is postulated as a co-factor in AIDS.
Also relevant was the fact that at this same time Dr. Leonard Hayflick, over at the Wistar Institute [one of the Koprowski Krowd] produced a study called “The Mycoplasma and Human Leukemia”.
Another important personnel addition to the NCI/NIH research group was Sol Spiegelman who joined in 1969. In this series of precis articles from the outline of our work-in-progress, The Crime Beyond Belief, we cannot go into detail about Spiegelman’s work, but to give you an idea we refer to the SVCP Progress Report #8, page 324. Here it is noted that Spiegelman co-authored a research report titled: “DNA polymerase activities in virions of VISNA VIRUS”
Another Gallo- Spiegelman link that is significant to our study is a biologist named Arsene Burny. Gallo introduces Burny as a ‘member’ of the Spiegelman ‘group’. For our purposes we need to note that Burny had first worked in Belgium [see article above: “The Belgians and the Portuguese”]. His special field was bovine leukemia virus [BLV], which is what Gallo was working with, but which he disingenuously named HTLV-1.Furthermore, Burny was a co-author with Spiegelman on the visna article noted above.
We could go on with more examples about the Gallo years at NIH, but we have made our point: when one looks behind Gallo’s obfuscating and selective details, one finds solid links to the mycoplasma and the visna virus that we started with.
Peter Dale Scott is an ex-patriot Canadian now living in California. Professor Scott has coined the phrase ‘negative template’ to refer to key details that are omitted in any so-called account of some event. Don’t look exclusively at those things that are revealed, suggests this profound scholar, look instead for the details that are omitted, if you wish to find the full story.
End of an Interlude
‘Negative template’ could be Robert Gallo’s middle name. One example out of many will illustrate what we mean.
In 1970 Gallo co-authored an article with Stringner S. Yang and Robert C. Ting. The title of the article is “RNA Dependent DNA Polymerase of Human Acute Leukemic Cells”. Gallo, in his Virus Hunting alludes to Ting, but makes no mention of Yang. No apparent problem there.
However, there is a problem in the fact that both Yang and Ting worked for Bionetics Research Laboratories and at the time Bionetics was a biological weapons contractor to the United States Government. Nowhere in the index of Gallo’s misinformative book does Bionetics or its principal, Litton Industries, appear. Again, Gallo deals with suggestive material simply by leaving out all possibly compromising references to such.
The fact is this: all the evidence that we have been able to seek out in the countless documents that are our source, makes it clear that Robert Gallo was the man with one foot in the government camp and one foot in the industrial camp, where he was charged with the responsibility for producing a smallpox vaccine for WHO, designed to plant the co-factors of AIDS (the mycoplasma and the visna virus in its BLV variant) in as many people of the Third World as could be enticed to accept the American’ gift’. He was charged with the task of making all the research sound something like a great war on cancer, while he was actually carrying out a secret Rockefeller/ Kissinger war on humanity.
But, when in 1983 Dr. Luc Montagnier of the Pasteur Institute in Paris identified a particle in the blood of AIDS victims which he knew was related to the disease agent which causes lymphadenopathy in humans and which he linked to a retrovirus, he called it Lymphadenopathy Associated Virus [LAV] and so pushed Gallo to claim that he had already isolated the disease agent. Typical.
But, our focus is upon the negative templates that Professor Scott suggests we look for, and in Gallo’s career one can hardly see the forest for templates! We can’t summarize the Gallo/ Bionetics collaboration here for lack of space, but we develop the criminal conspiracy in extensive detail in our forthcoming book The Crime Beyond Belief. In the meantime readers can refer to Leonard Horowitz dramatic book Emerging Viruses: AIDS & Ebola pages 79 to 84 for an excellent summary of much of what Gallo leaves out of his creative writing exercise.